EDGAR Filing Documents for 0001193125-24-183778

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001193125-24-183778

Filing Date

2024-07-24

Accepted

2024-07-24 16:10:33

Documents

Period of Report

2024-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q/A	d691902d10qa.htm iXBRL	10-Q/A	55423
2	EX-31.1	d691902dex311.htm	EX-31.1	4712
3	EX-31.2	d691902dex312.htm	EX-31.2	4674
	Complete submission text file	0001193125-24-183778.txt		246242

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	arqt-20240331.xsd	EX-101.SCH	4582
5	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	arqt-20240331_cal.xml	EX-101.CAL	658
6	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	arqt-20240331_def.xml	EX-101.DEF	14458
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	arqt-20240331_lab.xml	EX-101.LAB	19080
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	arqt-20240331_pre.xml	EX-101.PRE	15589
19	EXTRACTED XBRL INSTANCE DOCUMENT	d691902d10qa_htm.xml	XML	6605

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361

Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006

Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)